Tumor-infiltrating lymphocytes for the treatment of metastatic cancer-Reference-Cited by-同舟云学术

Tumor-infiltrating lymphocytes for the treatment of metastatic cancer

Published:2015-10-30 Issue:10 Volume:9 Page:1918-1935
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:

Author:

Geukes Foppen M.H.,Donia M.,Svane I.M.,Haanen J.B.A.G.

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1016/j.molonc.2015.10.018/fullpdf

Reference116 articles.

1. Signatures of mutational processes in human cancer;Alexandrov;Nature,2013

2. Adoptive cell therapy with tumor infiltrating lymphocytes and intermediate dose IL-2 for metastatic melanoma;Andersen;J. Immunother. Cancer,2014

3. CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells;Antony;J. Immunol,2005

4. Use of adoptive transfer of tumor-infiltrating lymphocytes alone or in combination with cisplatin-containing chemotherapy in patients with epithelial ovarian cancer;Aoki;Cancer Res,1991

5. High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993;Atkins;J. Clin. Oncol,1999

Cited by 96 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neutralizing IL-16 enhances the efficacy of targeting Aurora-A therapy in colorectal cancer with high lymphocyte infiltration through restoring anti-tumor immunity;Cell Death & Disease;2024-01-30

2. Vaccination and modern therapy of cervical cancer;Medical alphabet;2024-01-17

3. A replicating LCMV-based vaccine for the treatment of solid tumors;Molecular Therapy;2023-12

4. Attenuated Salmonella carrying siRNA-PD-L1 and radiation combinatorial therapy induces tumor regression on HCC through T cell-mediated immuno-enhancement;Cell Death Discovery;2023-08-28

5. Attenuated Salmonella carrying siRNA-PD-L1 and radiation combinatorial therapy induces tumor regression on HCC through T cell-mediated immuno-enhancement;2023-05-23